Kolexia
Picon Laurence Gastro-entérologie
Picon Laurence
Gastro-entérologie
Hôpital Trousseau Chambray lès Tours
Chambray-lès-Tours, France
56 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Occlusion intestinale Nécrose Maladie chronique Inflammation Sténose pathologique

Collaborateurs

Voir plus
Aubourg Alexandre
Aubourg Alexandre
Cabinet libéral, Chambray-lès-Tours, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Bouhnik Yoram
Bouhnik Yoram
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France
Nachury Maria
Nachury Maria
Hôpital Huriez, Lille, France

Industries

Voir plus
Janssen
11 collaboration(s)
Dernière en 2023
Abbvie
7 collaboration(s)
Dernière en 2021
Pfizer
6 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
USTAP: USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Essai Clinique (Janssen)   18 janvier 2024
Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID.
Clinical and translational gastroenterology   01 août 2023
Fisiología de la deglución normal
EMC - Otorrinolaringología   01 mai 2023
Fisiologia della deglutizione normale
EMC - Otorinolaringoiatria   01 mars 2023
P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
The lancet. Gastroenterology & hepatology   11 janvier 2023
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.
Journal of Crohn's & colitis   03 novembre 2022
SPARE: A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
Essai Clinique (Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives)   02 août 2022
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
Inflammatory bowel diseases   02 août 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.
Scandinavian journal of gastroenterology   18 juin 2022